IRF8 and lymphoma: In mice, the IRF8-mutant driven remodeling of the lymphoma microenvironment was diverse but consistently reflected a procancer profile (decrease in CD4, CD8, NK, and TFH1 and increase in Tregs and TFH cells) (62).